Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 10 Dec 2024

Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab

in Cancer Immunity and Immunotherapy

Jaejun Lee
Jae-Sung Yoo
Ji Hoon Kim
Dong Yeup Lee
Keungmo Yang
Bohyun Kim
Joon-Il Choi
Jeong Won Jang
Jong Young Choi
Seung Kew Yoon

Frontiers in Immunology

doi 10.3389/fimmu.2024.1506355

983 views

Review

Published on 10 Dec 2024

Remodeling of tumour microenvironment: strategies to overcome therapeutic resistance and innovate immunoengineering in triple-negative breast cancer

in Cancer Immunity and Immunotherapy

Desh Deepak Singh
Shafiul Haque
Youngsun Kim
Ihn Han
Dharmendra Kumar Yadav

Frontiers in Immunology

doi 10.3389/fimmu.2024.1455211

1,296 views

Original Research

Published on 10 Dec 2024

Integrating machine learning, bioinformatics and experimental verification to identify a novel prognostic marker associated with tumor immune microenvironment in head and neck squamous carcinoma

in Cancer Immunity and Immunotherapy

Xiaoxia Zeng
Dunhui Yang
Jin Zhang
Kang Li
Xijia Wang
Fang Ma
Xianqin Liao
Zhen Wang
Xianhai Zeng
Peng Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1501486

801 views

Original Research

Published on 10 Dec 2024

Decoding the prognostic landscape of LUAD: the interplay between N6-methyladenosine modification and immune microenvironment

in Cancer Immunity and Immunotherapy

Quan Chen
Weijun Wan
Qing Zhao
Juan Li
Yanli Xiong
Yuchuan Yuan
Lu Tang
Xiaofeng Wu
Wei Xing
Wei Guo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1514497

1,082 views

Original Research

Published on 09 Dec 2024

Clinical-scale, modular manufacturing of tumor-reactive TILs using a closed and automated culture system

in Cancer Immunity and Immunotherapy

Christina Völzke
Lisa Ehrhardt
Laura Fischer
Peter Maul
Carina Wenzel
Arina Riabinska
Elvira Criado-Moronati
Mike Dienstbier
Jessica Hassel
Danmei Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1483254

1,266 views

Review

Published on 09 Dec 2024

Long non-coding RNAs are involved in the crosstalk between cancer-associated fibroblasts and tumor cells

in Cancer Immunity and Immunotherapy

Chenbo Yang
Jiao Shu
Yiwei Li
Na Zhao
Xiaonan Liu
Xiangyu Tian
Zexin Sun
Muhammad Saud Tabish
Yichen Hong
Kuisheng Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1469918

794 views

Case Report

Published on 09 Dec 2024

Case report: Therapeutic response of front-line cadonilimab plus chemotherapy on patient with advanced lung adenocarcinoma harboring STK11 genetic aberration

in Cancer Immunity and Immunotherapy

Du Feng
Huixin Jiang
Gengjia Chen
Wenhui Guan
Lin Yi
Yue Zhu
Yijia Li
Gengda Huang
Bin He
Junlong Tang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1485358

1,075 views

Original Research

Published on 09 Dec 2024

Integrating necroptosis into pan-cancer immunotherapy: a new era of personalized treatment

in Cancer Immunity and Immunotherapy

Yan Gao
Sheng Chen
Lei Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1510079

908 views

Case Report

Published on 09 Dec 2024

Case report: A novel third-generation anti-CD19/CD22 CAR T-cells combined with auto-HSCT for relapsed Burkitt lymphoma

in Cancer Immunity and Immunotherapy

Xiaodan Luo
Ao Chen
Le Qin
Robert Weinkove
Rong Zhao
Ting Ye
Sihui Chen
Jianli Tang
Jianbo Liu
Jiayu Huang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1497736

1,448 views

Perspective

Published on 09 Dec 2024

What immunology has to say about pesticide safety

in Cancer Immunity and Immunotherapy

Adrián David Friedrich
Norberto Walter Zwirner

Frontiers in Immunology

doi 10.3389/fimmu.2024.1487805

755 views

Original Research

Published on 09 Dec 2024

Innovative strategies to optimise colorectal cancer immunotherapy through molecular mechanism insights

in Cancer Immunity and Immunotherapy

Quanjun Lin
Zhiqiang Wang
Jue Wang
Ming Xu
Xinyi Zhang
Peng Sun
Yihang Yuan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1509658

1,102 views

Original Research

Published on 09 Dec 2024

Chemo-free salvage treatment outperforms traditional chemotherapy in advanced lines of relapsed/refractory subcutaneous panniculitis-like T-cell lymphoma

in Cancer Immunity and Immunotherapy

Chao Chen
Jingjing Yin
Minghui Duan
Wei Wang
Danqing Zhao
Chong Wei
Congwei Jia
Wei Zhang
Daobin Zhou
Yan Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1476875

834 views

Mini Review

Published on 06 Dec 2024

Radioimmunotherapy: a game-changer for advanced non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Huichan Xue
Yunshang Chen
Yun Zhou

Frontiers in Immunology

doi 10.3389/fimmu.2024.1522508

1,335 views

Systematic Review

Published on 06 Dec 2024

Modular (universal) CAR-T platforms in vivo: a comprehensive systematic review

in Cancer Immunity and Immunotherapy

Afraa Mohammad
Anna Yurina
Tatiana Simonyan
Daniil Chistyakov
Rand Salman
Ksenia Zornikova
Elizaveta Minina
Apollinariya Bogolyubova

Frontiers in Immunology

doi 10.3389/fimmu.2024.1409665

1,209 views

Original Research

Published on 06 Dec 2024

Hypoxia reconstructed colorectal tumor microenvironment weakening anti-tumor immunity: construction of a new prognosis predicting model through transcriptome analysis

in Cancer Immunity and Immunotherapy

Ruizhi Zhang
Yisong Gao
Chong Li
Ruikang Tao
Gan Mao
Tianyu Song
Wenxiang Nie
Suao Liu
Kaixiong Tao
Wei Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1425687

845 views

Review

Published on 06 Dec 2024

Tumor-infiltrating lymphocytes in melanoma: from prognostic assessment to therapeutic applications

in Cancer Immunity and Immunotherapy

Meshack Bida
Thabiso Victor Miya
Rodney Hull
Zodwa Dlamini

Frontiers in Immunology

doi 10.3389/fimmu.2024.1497522

938 views

Navigation group

Articles

Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab

Remodeling of tumour microenvironment: strategies to overcome therapeutic resistance and innovate immunoengineering in triple-negative breast cancer

Integrating machine learning, bioinformatics and experimental verification to identify a novel prognostic marker associated with tumor immune microenvironment in head and neck squamous carcinoma

Decoding the prognostic landscape of LUAD: the interplay between N6-methyladenosine modification and immune microenvironment

Clinical-scale, modular manufacturing of tumor-reactive TILs using a closed and automated culture system

Long non-coding RNAs are involved in the crosstalk between cancer-associated fibroblasts and tumor cells

Case report: Therapeutic response of front-line cadonilimab plus chemotherapy on patient with advanced lung adenocarcinoma harboring STK11 genetic aberration

Integrating necroptosis into pan-cancer immunotherapy: a new era of personalized treatment

Case report: A novel third-generation anti-CD19/CD22 CAR T-cells combined with auto-HSCT for relapsed Burkitt lymphoma

What immunology has to say about pesticide safety

Innovative strategies to optimise colorectal cancer immunotherapy through molecular mechanism insights

Chemo-free salvage treatment outperforms traditional chemotherapy in advanced lines of relapsed/refractory subcutaneous panniculitis-like T-cell lymphoma

Radioimmunotherapy: a game-changer for advanced non-small cell lung cancer

Modular (universal) CAR-T platforms in vivo: a comprehensive systematic review

Hypoxia reconstructed colorectal tumor microenvironment weakening anti-tumor immunity: construction of a new prognosis predicting model through transcriptome analysis

Tumor-infiltrating lymphocytes in melanoma: from prognostic assessment to therapeutic applications